A group of medical editors and representatives from pharmaceutical companies has published "Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research." They acknowledge that "the credibility of industry-sponsored clinical research has suffered in recent years, undercut by reports of selective or biased disclosure of research results, ghostwriting and guest authorship, and inaccurate or incomplete reporting of potential conflicts of interest." Among the recommendations: improve disclosure of authorship contributions and writing assistance, and continue education on best publication practices to end ghostwriting and guest authorship; report adverse event data more transparently and in a more clinically meaningful manner; and transparently report statistical methods used in analysis.
To read the full, original article click on this link: AAAS Policy Alert
